Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome
Sponsor: Emory University
Listed as NCT02132195, this PHASE3 trial focuses on Nephrotic Syndrome and remains completed. Sponsored by Emory University, it has been updated 11 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2019 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 6 earlier versions
-
Feb 2019 — Jun 2019 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Jun 2018 — Feb 2019 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Dec 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
Jun 2017 — Dec 2017 [monthly]
Recruiting PHASE3
-
Feb 2017 — Jun 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Emory University
- Mallinckrodt
For direct contact, visit the study record on ClinicalTrials.gov .